Preventive medicine最新文献_第3页

Electronic nicotine delivery systems (ENDS): Frequency of use and smoking-cessation efforts among U.S. women of reproductive age 电子尼古丁输送系统（ENDS）：美国育龄妇女的使用频率和戒烟努力。

IF 4.3 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Preventive medicine

Pub Date : 2024-11-01 DOI: 10.1016/j.ypmed.2024.108020

Sulamunn R.M. Coleman , Janice Y. Bunn , Elias M. Klemperer , Marc Jerome P. Feinstein , Stephen T. Higgins

Objective

Reducing harm from combustible cigarette use among women of reproductive age (WRA) is critical given their potential vulnerability to multigenerational adverse impacts of cigarette smoking. Although electronic nicotine delivery systems (ENDS) are not approved smoking cessation aids in the US, many WRA who smoke report using ENDS to help quit smoking. Associations between ENDS use patterns and smoking-cessation efforts among US WRA remain unclear.

Methods

Using the Population Assessment of Tobacco and Health (PATH) Study, we examined whether baseline (Wave 3 or 4) ENDS use frequency predicted (a) making a cigarette quit attempt (QA) and (b) successful quitting by follow-up (Wave 4 or 5, respectively) among WRA (N = 2834; 72.1% non-Hispanic White).

Results

Daily ENDS use predicted greater adjusted odds of making a QA than non-daily (AOR = 1.63, 95% CI = 1.03, 2.59) and no ENDS use (AOR = 1.97, 95% CI = 1.23, 3.14), and greater odds of successful smoking cessation than non-daily use (AOR = 2.37, 95% CI = 1.31, 4.26). Daily ENDS use did not significantly improve odds of successful smoking cessation compared to no ENDS use (AOR = 1.62, 95% CI = 0.97, 2.69). Non-daily ENDS use did not significantly improve odds of making a QA (AOR = 1.21, 95% CI = 0.94, 1.56) and hindered successful smoking cessation compared to no ENDS use (AOR = 0.68, 95% CI = 0.48, 0.98).

Conclusions

These findings suggest that benefits of ENDS for smoking cessation in WRA may be greatest among those who use ENDS daily. WRA who choose to use ENDS to help quit would be well-informed by evidence that non-daily ENDS use may impede smoking cessation.

目的：鉴于育龄妇女（WRA）可能容易受到吸烟带来的多代不良影响，减少她们使用可燃卷烟的危害至关重要。尽管电子尼古丁递送系统（ENDS）在美国未被批准为戒烟辅助工具，但许多吸烟的育龄妇女表示使用ENDS来帮助戒烟。美国 WRA 使用 ENDS 的模式与戒烟努力之间的关系仍不清楚：利用烟草与健康人群评估（PATH）研究，我们研究了ENDS的基线使用频率（第3或第4波）是否预示着WRA（人数=2834；72.1%为非西班牙裔白人）中（a）尝试戒烟（QA）和（b）在随访（分别为第4或第5波）时成功戒烟：与非每日使用（AOR = 1.63，95% CI = 1.03，2.59）和不使用ENDS（AOR = 1.97，95% CI = 1.23，3.14）相比，每日使用ENDS可预测更高的调整后QA几率，与非每日使用（AOR = 2.37，95% CI = 1.31，4.26）相比，可预测更高的成功戒烟几率。与不使用ENDS相比，每天使用ENDS并不能显著提高成功戒烟的几率（AOR = 1.62，95% CI = 0.97，2.69）。与不使用ENDS相比，非每天使用ENDS并不能明显提高做出质量评估的几率（AOR = 1.21，95% CI = 0.94，1.56），而且会阻碍成功戒烟（AOR = 0.68，95% CI = 0.48，0.98）：这些研究结果表明，在每天使用ENDS的WRA中，ENDS对戒烟的益处可能最大。有证据表明，非每天使用ENDS可能会妨碍戒烟，这对选择使用ENDS帮助戒烟的WRA来说是一个很好的信息。

{"title":"Electronic nicotine delivery systems (ENDS): Frequency of use and smoking-cessation efforts among U.S. women of reproductive age","authors":"Sulamunn R.M. Coleman , Janice Y. Bunn , Elias M. Klemperer , Marc Jerome P. Feinstein , Stephen T. Higgins","doi":"10.1016/j.ypmed.2024.108020","DOIUrl":"10.1016/j.ypmed.2024.108020","url":null,"abstract":"<div><h3>Objective</h3><div>Reducing harm from combustible cigarette use among women of reproductive age (WRA) is critical given their potential vulnerability to multigenerational adverse impacts of cigarette smoking. Although electronic nicotine delivery systems (ENDS) are not approved smoking cessation aids in the US, many WRA who smoke report using ENDS to help quit smoking. Associations between ENDS use patterns and smoking-cessation efforts among US WRA remain unclear.</div></div><div><h3>Methods</h3><div>Using the Population Assessment of Tobacco and Health (PATH) Study, we examined whether baseline (Wave 3 or 4) ENDS use frequency predicted (a) making a cigarette quit attempt (QA) and (b) successful quitting by follow-up (Wave 4 or 5, respectively) among WRA (<em>N</em> = 2834; 72.1% non-Hispanic White).</div></div><div><h3>Results</h3><div>Daily ENDS use predicted greater adjusted odds of making a QA than non-daily (AOR = 1.63, 95% CI = 1.03, 2.59) and no ENDS use (AOR = 1.97, 95% CI = 1.23, 3.14), and greater odds of successful smoking cessation than non-daily use (AOR = 2.37, 95% CI = 1.31, 4.26). Daily ENDS use did not significantly improve odds of successful smoking cessation compared to no ENDS use (AOR = 1.62, 95% CI = 0.97, 2.69). Non-daily ENDS use did not significantly improve odds of making a QA (AOR = 1.21, 95% CI = 0.94, 1.56) and hindered successful smoking cessation compared to no ENDS use (AOR = 0.68, 95% CI = 0.48, 0.98).</div></div><div><h3>Conclusions</h3><div>These findings suggest that benefits of ENDS for smoking cessation in WRA may be greatest among those who use ENDS daily. WRA who choose to use ENDS to help quit would be well-informed by evidence that non-daily ENDS use may impede smoking cessation.</div></div>","PeriodicalId":20339,"journal":{"name":"Preventive medicine","volume":"188 ","pages":"Article 108020"},"PeriodicalIF":4.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141184416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

E-cigarette use and respiratory illnesses among U.S. adults: An analysis of the Population Assessment of Tobacco and Health Study 美国成年人使用电子烟与呼吸道疾病：烟草与健康人口评估研究分析。

IF 4.3 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Preventive medicine

Pub Date : 2024-11-01 DOI: 10.1016/j.ypmed.2024.108118

Adriana M. Eugene , Luisa N. Borrell

Introduction

Electronic cigarettes (e-cigarette) entered the United States marketplace in 2007. Because of the chemical composition of e-cigarette liquid, there are concerns related to its effects on respiratory illnesses.

Methods

Using Wave 4 (2016–2018) of the adult (≥18 years of age) Population Assessment of Tobacco and Health study, logistic regression was used to quantify the association between e-cigarette use and any respiratory illness (asthma, chronic bronchitis, COPD, emphysema, or other lung or respiratory conditions). Age, gender, and the use of other tobacco products were assessed as modifiers of this relationship via interactions on the additive and multiplicative scales.

Results

After adjustment, ever e-cigarette use was associated with a 1.32 (95 % confidence intervals [CI]:1.03, 1.69) greater odds of any respiratory illness compared with never e-cigarette users among U.S. adults. When comparing ever and never e-cigarette users, older adults (Odds Ratio [OR] = 1.65, 95 %CI:1.20, 2.26), and ever users of other tobacco products (OR = 1.77, 95 %CI:1.37, 2.29) had greater odds of reporting any respiratory illness than younger adults and those who never used other tobacco products. Among never e-cigarette users, men (OR = 1.51, 95 %CI:1.12, 2.04) were less likely to report any respiratory illness than women. Only the joint effect of age and e-cigarette use on any respiratory illness was statistically significant, suggesting this effect was greater than expected on the additive and multiplicative scales.

Conclusion

These findings suggest that the relationship between e-cigarette use and any respiratory illness varies with age. Interventions and policies to reduce e-cigarette use should target high-risk groups for any respiratory illness.

导言：电子香烟于 2007 年进入美国市场。由于电子烟液体的化学成分，人们担心其对呼吸系统疾病的影响：利用成人（≥18 岁）烟草与健康人口评估研究的第 4 波（2016-2018 年），使用逻辑回归量化电子烟使用与任何呼吸系统疾病（哮喘、慢性支气管炎、慢性阻塞性肺病、肺气肿或其他肺部或呼吸系统疾病）之间的关联。年龄、性别和使用其他烟草产品的情况通过加法和乘法量表上的交互作用被评估为这一关系的调节因素：经调整后，在美国成年人中，与从未使用过电子烟的人相比，曾经使用过电子烟的人患任何呼吸道疾病的几率比从未使用过电子烟的人高出 1.32（95 % 置信区间 [CI]：1.03, 1.69）。与曾经和从未使用过电子烟的人群相比，老年人（Odds Ratio [OR] = 1.65，95 %CI:1.20, 2.26）和曾经使用过其他烟草制品的人群（OR = 1.77，95 %CI:1.37, 2.29）报告患有任何呼吸道疾病的几率要高于年轻人和从未使用过其他烟草制品的人群。在从未使用过电子烟的人群中，男性（OR = 1.51，95 %CI:1.12, 2.04）报告任何呼吸道疾病的几率低于女性。只有年龄和使用电子烟对任何呼吸道疾病的共同影响具有统计学意义，表明这种影响大于加法和乘法量表的预期：这些研究结果表明，使用电子烟与任何呼吸道疾病之间的关系因年龄而异。减少电子烟使用的干预措施和政策应针对任何呼吸道疾病的高危人群。

{"title":"E-cigarette use and respiratory illnesses among U.S. adults: An analysis of the Population Assessment of Tobacco and Health Study","authors":"Adriana M. Eugene , Luisa N. Borrell","doi":"10.1016/j.ypmed.2024.108118","DOIUrl":"10.1016/j.ypmed.2024.108118","url":null,"abstract":"<div><h3>Introduction</h3><div>Electronic cigarettes (e-cigarette) entered the United States marketplace in 2007. Because of the chemical composition of e-cigarette liquid, there are concerns related to its effects on respiratory illnesses.</div></div><div><h3>Methods</h3><div>Using Wave 4 (2016–2018) of the adult (≥18 years of age) Population Assessment of Tobacco and Health study, logistic regression was used to quantify the association between e-cigarette use and any respiratory illness (asthma, chronic bronchitis, COPD, emphysema, or other lung or respiratory conditions). Age, gender, and the use of other tobacco products were assessed as modifiers of this relationship via interactions on the additive and multiplicative scales.</div></div><div><h3>Results</h3><div>After adjustment, ever e-cigarette use was associated with a 1.32 (95 % confidence intervals [CI]:1.03, 1.69) greater odds of any respiratory illness compared with never e-cigarette users among U.S. adults. When comparing ever and never e-cigarette users, older adults (Odds Ratio [OR] = 1.65, 95 %CI:1.20, 2.26), and ever users of other tobacco products (OR = 1.77, 95 %CI:1.37, 2.29) had greater odds of reporting any respiratory illness than younger adults and those who never used other tobacco products. Among never e-cigarette users, men (OR = 1.51, 95 %CI:1.12, 2.04) were less likely to report any respiratory illness than women. Only the joint effect of age and e-cigarette use on any respiratory illness was statistically significant, suggesting this effect was greater than expected on the additive and multiplicative scales.</div></div><div><h3>Conclusion</h3><div>These findings suggest that the relationship between e-cigarette use and any respiratory illness varies with age. Interventions and policies to reduce e-cigarette use should target high-risk groups for any respiratory illness.</div></div>","PeriodicalId":20339,"journal":{"name":"Preventive medicine","volume":"188 ","pages":"Article 108118"},"PeriodicalIF":4.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142056417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Differential effects of cigarette smoking on cardiovascular disease in females: A narrative review and call to action 吸烟对女性心血管疾病的不同影响：叙述性综述和行动呼吁。

IF 4.3 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Preventive medicine

Pub Date : 2024-11-01 DOI: 10.1016/j.ypmed.2024.108013

Diann E. Gaalema , Joseph Allencherril , Sherrie Khadanga , Elias Klemperer

Objective

Cigarette smoking continues to be a major driver in the incidence and progression of cardiovascular disease (CVD). As females become an increasingly larger fraction of those who smoke it is imperative that the sex-specific effects of smoking be further explored and acted upon.

Methods

This narrative review describes current evidence on the differential effects of smoking on CVD in females and the need to improve treatment.

Results

Evidence to date suggests that smoking has disproportionately negative effects on the cardiovascular (CV) system in females, especially in those who are younger. Usually, the onset of CVD is later in females than males, but smoking decreases or eliminates this gap. Females are also more likely to develop types of CVD closely tied to smoking, such as ST-elevated myocardial infarctions, with even higher rates among those who are younger. Possible mechanisms for these worse outcomes in females include a complex interplay between nicotine, other products of combusted cigarettes, and hormones. Sex differences also exist in treatment for smoking. In females, Varenicline appears more effective than either Bupropion or nicotine replacement therapy while in males, all three therapies show similar efficacy. Disparities in smoking are also apparent in secondary prevention settings. Females and males are entering secondary prevention with equal rates of smoking, with potentially higher levels of exposure to the byproducts of smoking in females.

Conclusions

These disproportionately negative outcomes for females who smoke require additional research and these persisting rates of smoking suggest a need for female-specific approaches for treating smoking.

目的：吸烟仍然是导致心血管疾病（CVD）发病和恶化的主要因素。随着女性吸烟者的比例越来越大，必须进一步探讨吸烟的性别特异性影响并采取相应措施：本叙述性综述介绍了吸烟对女性心血管疾病的不同影响的现有证据以及改善治疗的必要性：迄今为止的证据表明，吸烟对女性心血管系统的负面影响尤为严重，尤其是对年轻女性。通常，女性心血管疾病的发病时间晚于男性，但吸烟会缩小或消除这一差距。女性也更容易患上与吸烟密切相关的心血管疾病，如ST段抬高型心肌梗死，而年轻女性的发病率更高。女性吸烟导致不良后果的可能机制包括尼古丁、燃烧香烟的其他产物和荷尔蒙之间复杂的相互作用。在吸烟治疗方面也存在性别差异。在女性中，伐尼克兰似乎比安非他酮或尼古丁替代疗法更有效，而在男性中，这三种疗法显示出相似的疗效。在二级预防中，吸烟率的差异也很明显。女性和男性在进入二级预防时的吸烟率相当，而女性接触吸烟副产品的程度可能更高：女性吸烟者的这些不成比例的负面结果需要更多的研究，而这些持续存在的吸烟率表明，需要采取针对女性的方法来治疗吸烟。

{"title":"Differential effects of cigarette smoking on cardiovascular disease in females: A narrative review and call to action","authors":"Diann E. Gaalema , Joseph Allencherril , Sherrie Khadanga , Elias Klemperer","doi":"10.1016/j.ypmed.2024.108013","DOIUrl":"10.1016/j.ypmed.2024.108013","url":null,"abstract":"<div><h3>Objective</h3><div>Cigarette smoking continues to be a major driver in the incidence and progression of cardiovascular disease (CVD). As females become an increasingly larger fraction of those who smoke it is imperative that the sex-specific effects of smoking be further explored and acted upon.</div></div><div><h3>Methods</h3><div>This narrative review describes current evidence on the differential effects of smoking on CVD in females and the need to improve treatment.</div></div><div><h3>Results</h3><div><span>Evidence to date suggests that smoking has disproportionately negative effects on the cardiovascular (CV) system in females, especially in those who are younger. Usually, the onset of CVD is later in females than males, but smoking decreases or eliminates this gap. Females are also more likely to develop types of CVD closely tied to smoking, such as ST-elevated myocardial infarctions<span>, with even higher rates among those who are younger. Possible mechanisms for these worse outcomes in females include a complex interplay between nicotine, other products of combusted cigarettes, and hormones. Sex differences also exist in treatment for smoking. In females, </span></span>Varenicline<span> appears more effective than either Bupropion<span> or nicotine replacement therapy while in males, all three therapies show similar efficacy. Disparities in smoking are also apparent in secondary prevention settings. Females and males are entering secondary prevention with equal rates of smoking, with potentially higher levels of exposure to the byproducts of smoking in females.</span></span></div></div><div><h3>Conclusions</h3><div>These disproportionately negative outcomes for females who smoke require additional research and these persisting rates of smoking suggest a need for female-specific approaches for treating smoking.</div></div>","PeriodicalId":20339,"journal":{"name":"Preventive medicine","volume":"188 ","pages":"Article 108013"},"PeriodicalIF":4.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141180563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Reprint of: Examining U.S. disparities in smoking among rural versus urban women of reproductive age: 2002–2019 重印本：研究美国农村与城市育龄妇女吸烟的差异：2002-2019 年。

IF 4.3 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Preventive medicine

Pub Date : 2024-11-01 DOI: 10.1016/j.ypmed.2024.108115

Stephen T. Higgins , Tyler Erath , Fang-Fang Chen

Objective

This study is part of a programmatic investigation of rural disparities in cigarette smoking examining disparities in smoking prevalence and for the first-time quit ratios among adult women of reproductive age (18–44 years), a highly vulnerable population due to risk for multigenerational adverse effects.

Methods

Data came from 18 years (2002–2019) of the U.S. National Survey on Drug Use and Health (NSDUH) among women (n = 280,626) categorized by rural-urban residence, pregnancy status, using weighted logistic regression models testing time trends and controlling for well-established sociodemographic predictors of smoking (race/ethnicity, education, income). Concerns regarding changes in survey methods used before 2002 and after 2019 precluded inclusion of earlier and more recent survey years in the present study.

Results

Overall smoking prevalence across years was greater in rural than urban residents (adjusted odds ratio [AOR] = 1.11; 95%CI, 1.07–1.15; P < .001) including those not-pregnant (AOR = 1.10; 1.07–1.14; P < .001) and pregnant (AOR = 1.29; 1.09–1.52; P < .001). Overall quit ratios across years were lower in rural than urban residents (AOR = 0.93; 0.87–0.99; P < .001) including those not-pregnant (AOR = 0.93; 0.88–1.00, P = .035) and pregnant (AOR = 0.78; 0.62–0.99; P = .039). Interactions of rural versus urban residence with study years for prevalence and quit ratios overall and by pregnancy status are detailed in the main text.

Conclusions

These results support a longstanding and robust rural disparity in smoking prevalence among women of reproductive age including those currently pregnant and provides novel evidence that differences in smoking cessation contribute to this disparity further underscoring a need for greater access to evidence-based tobacco control and regulatory interventions in rural regions.

研究目的本研究是对农村地区吸烟差异进行的一项计划性调查的一部分，调查对象为育龄成年女性（18-44 岁）中吸烟率和首次戒烟率的差异：数据来自美国全国药物使用和健康调查（NSDUH）18 年（2002-2019 年）的数据，按城乡居住地和怀孕状况对妇女（n = 280,626 人）进行分类，使用加权逻辑回归模型检验时间趋势，并控制已确立的吸烟社会人口预测因素（种族/民族、教育、收入）。考虑到 2002 年之前和 2019 年之后调查方法的变化，本研究未将较早和较近的调查年份纳入其中：结果：农村居民在不同年份的总体吸烟率高于城市居民（调整后的几率比 [AOR] = 1.11；95%CI，1.07-1.15；P 结论：这些结果支持了农村居民吸烟率的长期稳健增长：这些结果表明，农村育龄妇女（包括怀孕妇女）的吸烟率长期存在巨大差异，并提供了新的证据表明，戒烟方面的差异导致了这种差异，这进一步强调了农村地区需要更多的循证烟草控制和监管干预措施。

{"title":"Reprint of: Examining U.S. disparities in smoking among rural versus urban women of reproductive age: 2002–2019","authors":"Stephen T. Higgins , Tyler Erath , Fang-Fang Chen","doi":"10.1016/j.ypmed.2024.108115","DOIUrl":"10.1016/j.ypmed.2024.108115","url":null,"abstract":"<div><h3>Objective</h3><div>This study is part of a programmatic investigation of rural disparities in cigarette smoking examining disparities in smoking prevalence and for the first-time quit ratios among adult women of reproductive age (18–44 years), a highly vulnerable population due to risk for multigenerational adverse effects.</div></div><div><h3>Methods</h3><div>Data came from 18 years (2002–2019) of the U.S. National Survey on Drug Use and Health (NSDUH) among women (<em>n</em> = 280,626) categorized by rural-urban residence, pregnancy status, using weighted logistic regression models testing time trends and controlling for well-established sociodemographic predictors of smoking (race/ethnicity, education, income). Concerns regarding changes in survey methods used before 2002 and after 2019 precluded inclusion of earlier and more recent survey years in the present study.</div></div><div><h3>Results</h3><div>Overall smoking prevalence across years was greater in rural than urban residents (adjusted odds ratio [AOR] = 1.11; 95%CI, 1.07–1.15; <em>P</em> < .001) including those not-pregnant (AOR = 1.10; 1.07–1.14; <em>P</em> < .001) and pregnant (AOR = 1.29; 1.09–1.52; P < .001). Overall quit ratios across years were lower in rural than urban residents (AOR = 0.93; 0.87–0.99; <em>P</em> < .001) including those not-pregnant (AOR = 0.93; 0.88–1.00, <em>P</em> = .035) and pregnant (AOR = 0.78; 0.62–0.99; <em>P</em> = .039). Interactions of rural versus urban residence with study years for prevalence and quit ratios overall and by pregnancy status are detailed in the main text.</div></div><div><h3>Conclusions</h3><div>These results support a longstanding and robust rural disparity in smoking prevalence among women of reproductive age including those currently pregnant and provides novel evidence that differences in smoking cessation contribute to this disparity further underscoring a need for greater access to evidence-based tobacco control and regulatory interventions in rural regions.</div></div>","PeriodicalId":20339,"journal":{"name":"Preventive medicine","volume":"188 ","pages":"Article 108115"},"PeriodicalIF":4.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142081324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Reprint of: Smoking and pulmonary health in women: A narrative review and behavioral health perspective 重印本：女性吸烟与肺部健康：叙述性综述和行为健康视角。

IF 4.3 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Preventive medicine

Pub Date : 2024-11-01 DOI: 10.1016/j.ypmed.2024.108113

Katherine E. Menson , Sulamunn R.M. Coleman

Objective

Cigarette smoking prevalence has declined slower among women than men, and smoking-related pulmonary disease (PD) has risen among women. Given these trends, there is a critical need to understand and mitigate PD risk among women who smoke. The purpose of this narrative review and commentary is to highlight important evidence from the literature on smoking and PD among women.

Methods

This review focuses broadly on examining cigarette smoking and PD among women within six topic areas: (1) demographic characteristics and prevalence of smoking, (2) smoking behavior, (3) lung cancer, (4) obstructive PD, (5) diagnostic and treatment disparities, and (6) gaps in the literature and potential directions for future research and treatment.

Results

Growing evidence indicates that compared to men, women are at increased risk for developing smoking-related PD and poorer PD outcomes. Gender disparities in smoking-related PD may be largely accounted for by genetic differences and sex hormones contributing to PD pathogenesis and presentation, smoking behavior, nicotine dependence, and pathogen/carcinogen clearance. Moreover, gender disparities in smoking-related PD may be exacerbated by important social determinants (e.g., women with less formal education and those from minoritized groups may be at especially high risk for poor PD outcomes due to higher rates of smoking).

Conclusion

Rising rates of smoking-related PD among women risk widening diagnostic and treatment disparities. Ongoing research is needed to explore potentially complex relationships between sex, gender, and smoking-related PD processes and outcomes, and to improve smoking-cessation and PD treatment for women.

目的：女性吸烟率的下降速度慢于男性，而与吸烟相关的肺部疾病（PD）在女性中有所上升。鉴于这些趋势，我们亟需了解并降低吸烟女性患肺部疾病的风险。这篇叙述性综述和评论旨在强调女性吸烟和肺部疾病文献中的重要证据：方法：本综述主要从以下六个方面对女性吸烟与帕金森病进行研究：（1）人口特征和吸烟率；（2）吸烟行为；（3）肺癌；（4）阻塞性帕金森病；（5）诊断和治疗差异；（6）文献中的空白以及未来研究和治疗的潜在方向：越来越多的证据表明，与男性相比，女性罹患与吸烟相关的帕金森病的风险更高，且帕金森病的治疗效果更差。与吸烟相关的帕金森病的性别差异可能在很大程度上是由遗传差异和性激素造成的，而遗传差异和性激素又与帕金森病的发病机制和表现、吸烟行为、尼古丁依赖以及病原体/致癌物质清除有关。此外，与吸烟相关的帕金森病的性别差异可能会因重要的社会决定因素而加剧（例如，正规教育程度较低的女性和来自少数群体的女性可能因吸烟率较高而特别容易出现帕金森病的不良后果）：结论：女性中与吸烟相关的帕金森病发病率不断上升，有可能扩大诊断和治疗方面的差异。需要持续开展研究，探索性、性别和吸烟相关的帕金森病过程和结果之间潜在的复杂关系，并改善女性的戒烟和帕金森病治疗。

{"title":"Reprint of: Smoking and pulmonary health in women: A narrative review and behavioral health perspective","authors":"Katherine E. Menson , Sulamunn R.M. Coleman","doi":"10.1016/j.ypmed.2024.108113","DOIUrl":"10.1016/j.ypmed.2024.108113","url":null,"abstract":"<div><h3>Objective</h3><div>Cigarette smoking prevalence has declined slower among women than men, and smoking-related pulmonary disease (PD) has risen among women. Given these trends, there is a critical need to understand and mitigate PD risk among women who smoke. The purpose of this narrative review and commentary is to highlight important evidence from the literature on smoking and PD among women.</div></div><div><h3>Methods</h3><div>This review focuses broadly on examining cigarette smoking and PD among women within six topic areas: (1) demographic characteristics and prevalence of smoking, (2) smoking behavior, (3) lung cancer, (4) obstructive PD, (5) diagnostic and treatment disparities, and (6) gaps in the literature and potential directions for future research and treatment.</div></div><div><h3>Results</h3><div>Growing evidence indicates that compared to men, women are at increased risk for developing smoking-related PD and poorer PD outcomes. Gender disparities in smoking-related PD may be largely accounted for by genetic differences and sex hormones contributing to PD pathogenesis and presentation, smoking behavior, nicotine dependence, and pathogen/carcinogen clearance. Moreover, gender disparities in smoking-related PD may be exacerbated by important social determinants (e.g., women with less formal education and those from minoritized groups may be at especially high risk for poor PD outcomes due to higher rates of smoking).</div></div><div><h3>Conclusion</h3><div>Rising rates of smoking-related PD among women risk widening diagnostic and treatment disparities. Ongoing research is needed to explore potentially complex relationships between sex, gender, and smoking-related PD processes and outcomes, and to improve smoking-cessation and PD treatment for women.</div></div>","PeriodicalId":20339,"journal":{"name":"Preventive medicine","volume":"188 ","pages":"Article 108113"},"PeriodicalIF":4.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11563853/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142093689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Behavior change, health, and health disparities 2024: Smoking and other tobacco use among women and girls 行为改变、健康和健康差异 2024：妇女和女童吸烟及其他烟草使用情况。

IF 4.3 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Preventive medicine

Pub Date : 2024-11-01 DOI: 10.1016/j.ypmed.2024.108155

Stephen T. Higgins

This Special Issue (SI) of Preventive Medicine is the 11th in an annual series on behavior change, health, and health disparities. The theme of this 2024 issue is Smoking and Other Tobacco Use among Women and Girls. Cigarette smoking remains the single most preventable cause of death in the U.S., causing the premature death of more than 200,000 U.S. women annually, a mortality rate that far exceeds levels from conditions more commonly associated with premature death in women (e.g., breast cancer). Of course, cigarette smoking among women and girls is also a well-known cause of intergenerational adverse health effects. Women and girls are also using e-cigarettes and many other tobacco products that are flooding the U.S. tobacco marketplace. This SI includes eleven peer-reviewed articles that advance knowledge across a wide range of topics on disproportionate adverse effects, prevalence, and risk factors for cigarette smoking and other tobacco use in women and girls.

本期《预防医学》特刊（SI）是关于行为改变、健康和健康差异的年度系列的第 11 期。本期特刊的主题是 "妇女和女孩吸烟及其他烟草使用"。在美国，吸烟仍然是唯一最可预防的死因，每年导致 20 多万美国妇女过早死亡，其死亡率远远超过更常见的与妇女过早死亡有关的疾病（如乳腺癌）。当然，妇女和女童吸烟也是造成代际不良健康影响的一个众所周知的原因。妇女和女孩还在使用电子烟和其他许多充斥美国烟草市场的烟草产品。本 SI 共收录了 11 篇经同行评审的文章，这些文章就妇女和女童吸烟及其他烟草使用的不成比例的不良影响、流行率和风险因素等广泛主题增进了知识。

引用次数: 0

Emotional barriers pose the greatest threat to cervical cancer screening for young adult women in the United Kingdom 在英国，情感障碍是对年轻成年女性进行宫颈癌筛查的最大威胁。

IF 4.3 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Preventive medicine

Pub Date : 2024-10-30 DOI: 10.1016/j.ypmed.2024.108160

Karagh J. Brennan, Jonathon L. Reay

Objective

Low cervical screening coverage rate is the root-cause of cervical cancer mortality in the United Kingdom (UK), with 99 % of deaths being considered preventable. Research has consistently categorised reasons for non-attendance into emotional, practical, and cognitive barriers. Despite this, public health interventions have been unable to improve coverage rates. We propose a lifespan perspective is needed, to enable targeted interventions at appropriate milestones (i.e., common life events) during a woman's life. We start this lifespan perspective by investigating the perceived barriers young women report, who have and have not yet been invited to their first cervical screen (i.e., a common life event).

Methods

Twenty-nine women not yet invited to their first cervical screen and twenty women who confirmed they received their invite and confirmed attendance status, rated the likelihood of emotional, practical, and cognitive barriers affecting their attendance at their next cervical screen. Data collected between January and April 2018.

Results

Women who did not attend their first screen, rated emotional barriers significantly higher than all groups, and cognitive barriers higher than those women who did attend. Results highlight, for the first time, that commonly reported barriers are present up to seven years prior to a woman's first eligible cervical screen, with emotional barriers rated most strongly.

Conclusion

Emotional barriers pose the greatest threat to cervical screening attendance in young adult women. Interventions should start at school to encourage cervical screening to be viewed as routine healthcare. Future research should continue a lifespan perspective, indexed to common life events.

目的：宫颈癌筛查覆盖率低是导致英国宫颈癌死亡的根本原因，其中 99% 的死亡被认为是可以预防的。研究一直将不参加筛查的原因分为情感障碍、实际障碍和认知障碍。尽管如此，公共卫生干预措施仍无法提高覆盖率。我们提出需要从生命周期的角度出发，在妇女一生中适当的里程碑（即常见的生命事件）上采取有针对性的干预措施。我们从生命周期的角度出发，调查了已经和尚未被邀请进行首次宫颈筛查（即常见的生命事件）的年轻女性所反映的感知障碍：29名尚未受邀参加首次宫颈筛查的女性和20名确认收到邀请并确认出席情况的女性，对影响她们参加下一次宫颈筛查的情感、实际和认知障碍的可能性进行评分。数据收集时间为 2018 年 1 月至 4 月：未参加首次筛查的妇女对情感障碍的评分明显高于所有组别，对认知障碍的评分高于参加筛查的妇女。结果首次强调，在妇女首次接受合格宫颈筛查之前的七年内，普遍报告的障碍都存在，其中情感障碍的评价最高：结论：情感障碍对年轻成年女性参加宫颈筛查构成了最大的威胁。干预措施应从学校开始，鼓励将宫颈筛查视为常规保健。未来的研究应继续从生命周期的角度出发，以常见的生活事件为索引。

{"title":"Emotional barriers pose the greatest threat to cervical cancer screening for young adult women in the United Kingdom","authors":"Karagh J. Brennan, Jonathon L. Reay","doi":"10.1016/j.ypmed.2024.108160","DOIUrl":"10.1016/j.ypmed.2024.108160","url":null,"abstract":"<div><h3>Objective</h3><div>Low cervical screening coverage rate is the root-cause of cervical cancer mortality in the United Kingdom (UK), with 99 % of deaths being considered preventable. Research has consistently categorised reasons for non-attendance into emotional, practical, and cognitive barriers. Despite this, public health interventions have been unable to improve coverage rates. We propose a lifespan perspective is needed, to enable targeted interventions at appropriate milestones (i.e., common life events) during a woman's life. We start this lifespan perspective by investigating the perceived barriers young women report, who have and have not yet been invited to their first cervical screen (i.e., a common life event).</div></div><div><h3>Methods</h3><div>Twenty-nine women not yet invited to their first cervical screen and twenty women who confirmed they received their invite and confirmed attendance status, rated the likelihood of emotional, practical, and cognitive barriers affecting their attendance at their next cervical screen. Data collected between January and April 2018.</div></div><div><h3>Results</h3><div>Women who did not attend their first screen, rated emotional barriers significantly higher than all groups, and cognitive barriers higher than those women who did attend. Results highlight, for the first time, that commonly reported barriers are present up to seven years prior to a woman's first eligible cervical screen, with emotional barriers rated most strongly.</div></div><div><h3>Conclusion</h3><div>Emotional barriers pose the greatest threat to cervical screening attendance in young adult women. Interventions should start at school to encourage cervical screening to be viewed as routine healthcare. Future research should continue a lifespan perspective, indexed to common life events.</div></div>","PeriodicalId":20339,"journal":{"name":"Preventive medicine","volume":"189 ","pages":"Article 108160"},"PeriodicalIF":4.3,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142564724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Impact of perceived neighborhood social cohesion on vaccination intentions in the post-pandemic era 后流行病时代邻里社会凝聚力对疫苗接种意愿的影响。

IF 4.3 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Preventive medicine

Pub Date : 2024-10-29 DOI: 10.1016/j.ypmed.2024.108158

Anna L. Chupak , Caroline Rudisill , Sayward Harrison , Katie Linvill , Joan Costa-Font , Peiyin Hung , Xiaoming Li

Objective

To examine the relationship between perceived neighborhood social cohesion (NSC) and intentions to obtain seasonal influenza and COVID-19 vaccines among US adults post COVID-19 pandemic.

Methods

We conducted a cross-sectional, nationally representative survey of US residents (N = 2189) in May 2023 on their perceived NSC, COVID-19 and seasonal influenza vaccination intentions, healthcare access, perceived risk of COVID-19 or flu infection, loneliness, and trust in doctors. We used bivariate probit regressions to examine joint associations between perceived NSC and intentions to receive influenza and COVID-19 vaccines, controlling for several participant characteristics (e.g., race).

Results

2164 respondents provided consent to study questions. Trust-related NSC (trust in neighbors) was positively associated with intentions to become vaccinated against both influenza and COVID-19 viruses. Higher relational NSC (perception of a close-knit neighborhood) was positively associated while higher value-based NSC (perception that neighbors share the same values) was negatively associated with intentions to become vaccinated against COVID-19. Healthcare access, perceived risk of infection (COVID-19 or flu), and trust in doctors were positively associated with intentions to become vaccinated against both viruses.

Conclusions

In a post-pandemic era, higher trust-related and relational, perceived NSC (vaccine-dependent), greater access to healthcare, higher perceived risk of infection, and greater trust in doctors were related to higher influenza and COVID-19 vaccination intentions, while higher value-based NSC was related to lower COVID-19 vaccination intentions among US adults. Thus, specific aspects of NSC, healthcare access barriers, misinformation on infection risk, and medical mistrust may influence an individual's willingness and ultimate decision to become vaccinated.

目的研究COVID-19大流行后美国成年人感知的邻里社会凝聚力（NSC）与接种季节性流感疫苗和COVID-19疫苗意愿之间的关系：我们于 2023 年 5 月对美国居民（N = 2189）进行了一项具有全国代表性的横断面调查，调查内容包括他们感知到的邻里社会凝聚力、COVID-19 和季节性流感疫苗接种意向、医疗保健获取途径、感知到的 COVID-19 或流感感染风险、孤独感以及对医生的信任度。我们使用双变量 probit 回归法来检验感知到的 NSC 与接种流感疫苗和 COVID-19 疫苗的意愿之间的关联，同时控制了一些受访者特征（如种族）。与信任相关的 NSC（对邻居的信任）与接种流感疫苗和 COVID-19 疫苗的意愿呈正相关。较高的关系型 NSC（认为邻里关系紧密）与接种 COVID-19 疫苗的意愿呈正相关，而较高的价值型 NSC（认为邻里价值观相同）与接种 COVID-19 疫苗的意愿呈负相关。医疗服务的可及性、感知到的感染风险（COVID-19 或流感）以及对医生的信任与接种这两种病毒疫苗的意愿呈正相关：结论：在后大流行病时代，美国成年人中较高的信任相关性和关系相关性、感知到的NSC（疫苗依赖性）、较高的医疗保健可及性、较高的感知感染风险以及对医生的较高信任度与较高的流感和COVID-19疫苗接种意愿有关，而较高的基于价值的NSC与较低的COVID-19疫苗接种意愿有关。因此，NSC 的特定方面、获得医疗保健的障碍、关于感染风险的错误信息以及对医疗的不信任可能会影响个人接种疫苗的意愿和最终决定。

{"title":"Impact of perceived neighborhood social cohesion on vaccination intentions in the post-pandemic era","authors":"Anna L. Chupak , Caroline Rudisill , Sayward Harrison , Katie Linvill , Joan Costa-Font , Peiyin Hung , Xiaoming Li","doi":"10.1016/j.ypmed.2024.108158","DOIUrl":"10.1016/j.ypmed.2024.108158","url":null,"abstract":"<div><h3>Objective</h3><div>To examine the relationship between perceived neighborhood social cohesion (NSC) and intentions to obtain seasonal influenza and COVID-19 vaccines among US adults post COVID-19 pandemic.</div></div><div><h3>Methods</h3><div>We conducted a cross-sectional, nationally representative survey of US residents (<em>N</em> = 2189) in May 2023 on their perceived NSC, COVID-19 and seasonal influenza vaccination intentions, healthcare access, perceived risk of COVID-19 or flu infection, loneliness, and trust in doctors. We used bivariate probit regressions to examine joint associations between perceived NSC and intentions to receive influenza and COVID-19 vaccines, controlling for several participant characteristics (e.g., race).</div></div><div><h3>Results</h3><div>2164 respondents provided consent to study questions. Trust-related NSC (trust in neighbors) was positively associated with intentions to become vaccinated against both influenza and COVID-19 viruses. Higher relational NSC (perception of a close-knit neighborhood) was positively associated while higher value-based NSC (perception that neighbors share the same values) was negatively associated with intentions to become vaccinated against COVID-19. Healthcare access, perceived risk of infection (COVID-19 or flu), and trust in doctors were positively associated with intentions to become vaccinated against both viruses.</div></div><div><h3>Conclusions</h3><div>In a post-pandemic era, higher trust-related and relational, perceived NSC (vaccine-dependent), greater access to healthcare, higher perceived risk of infection, and greater trust in doctors were related to higher influenza and COVID-19 vaccination intentions, while higher value-based NSC was related to lower COVID-19 vaccination intentions among US adults. Thus, specific aspects of NSC, healthcare access barriers, misinformation on infection risk, and medical mistrust may influence an individual's willingness and ultimate decision to become vaccinated.</div></div>","PeriodicalId":20339,"journal":{"name":"Preventive medicine","volume":"189 ","pages":"Article 108158"},"PeriodicalIF":4.3,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Ikigai and use of preventive healthcare services in Germany Ikigai 和德国预防保健服务的使用情况。

IF 4.3 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Preventive medicine

Pub Date : 2024-10-29 DOI: 10.1016/j.ypmed.2024.108159

André Hajek , Angelina R. Sutin , Antonio Terracciano , Martina Luchetti , Yannick Stephan , Karl Peltzer , Hans-Helmut König

Objective

This study examined the association between ikigai (a Japanese concept akin to purpose in life or a rationale for existence) and use of preventive healthcare services.

Methods

Data were gathered in August and September of 2023 from a quota-based sample of 5000 individuals living in Germany (18 to 74 years). This sampling ensured representation across gender, age groups, and federal states to reflect the adult population of Germany. The recently validated German version of the Ikigai-9 scale (Ikigai-9-G) was used to assess ikigai. Outcomes were regular cancer screenings, flu vaccination, and routine health check-ups. Multiple logistic regressions were used.

Results

Ikigai was associated with higher odds of regular use of preventive healthcare services (regular flu vaccinations: OR = 1.01, 95 % CI: 1.002 to 1.02; regular cancer screenings: OR = 1.01, 95 % CI: 1.004 to 1.02; routine health check-ups: OR = 1.02, 95 % CI: 1.01 to 1.03), adjusting for sociodemographic, lifestyle, and health-related factors. The association between ikigai and preventive healthcare was not moderated by gender, age, or education.

Conclusion

Higher ikigai is associated with preventive health measures, independent of key covariates. These findings are consistent with the literature on ikigai and better health-related outcomes and subjective well-being. Ikigai may help point to new ways to counter the low use of preventive services in Germany.

研究目的本研究探讨了 "ikigai"（一种类似于生活目的或存在理由的日本概念）与使用预防性医疗服务之间的关系：数据收集于 2023 年 8 月和 9 月，从居住在德国的 5000 名个人（18 至 74 岁）中进行配额抽样。这种抽样确保了不同性别、年龄组和联邦州的代表性，以反映德国的成年人口。采用最近验证的德文版 Ikigai-9 量表（Ikigai-9-G）来评估 ikigai。结果包括定期癌症筛查、流感疫苗接种和常规健康检查。研究采用了多重逻辑回归：结果：Ikigai 与较高的定期使用预防性医疗保健服务的几率相关（定期接种流感疫苗：OR = 1.01，95 % CI：1.002 至 1.02；定期进行癌症筛查：OR=1.01，95 % CI：1.004 至 1.02；常规健康检查：OR=1.02，95 % CI：1.01 至 1.03），并对社会人口、生活方式和健康相关因素进行了调整。ikigai与预防性保健之间的关系不受性别、年龄或教育程度的影响：结论：较高的ikigai与预防性保健措施相关，不受主要协变量的影响。这些发现与有关 "ikigai "与更好的健康相关结果和主观幸福感的文献相一致。在德国，Ikigai 可能有助于找到新的方法来应对预防性服务使用率低的问题。

{"title":"Ikigai and use of preventive healthcare services in Germany","authors":"André Hajek , Angelina R. Sutin , Antonio Terracciano , Martina Luchetti , Yannick Stephan , Karl Peltzer , Hans-Helmut König","doi":"10.1016/j.ypmed.2024.108159","DOIUrl":"10.1016/j.ypmed.2024.108159","url":null,"abstract":"<div><h3>Objective</h3><div>This study examined the association between <em>ikigai</em> (a Japanese concept akin to purpose in life or a rationale for existence) and use of preventive healthcare services.</div></div><div><h3>Methods</h3><div>Data were gathered in August and September of 2023 from a quota-based sample of 5000 individuals living in Germany (18 to 74 years). This sampling ensured representation across gender, age groups, and federal states to reflect the adult population of Germany. The recently validated German version of the Ikigai-9 scale (Ikigai-9-G) was used to assess ikigai. Outcomes were regular cancer screenings, flu vaccination, and routine health check-ups. Multiple logistic regressions were used.</div></div><div><h3>Results</h3><div>Ikigai was associated with higher odds of regular use of preventive healthcare services (regular flu vaccinations: OR = 1.01, 95 % CI: 1.002 to 1.02; regular cancer screenings: OR = 1.01, 95 % CI: 1.004 to 1.02; routine health check-ups: OR = 1.02, 95 % CI: 1.01 to 1.03), adjusting for sociodemographic, lifestyle, and health-related factors. The association between ikigai and preventive healthcare was not moderated by gender, age, or education.</div></div><div><h3>Conclusion</h3><div>Higher ikigai is associated with preventive health measures, independent of key covariates. These findings are consistent with the literature on ikigai and better health-related outcomes and subjective well-being. Ikigai may help point to new ways to counter the low use of preventive services in Germany.</div></div>","PeriodicalId":20339,"journal":{"name":"Preventive medicine","volume":"189 ","pages":"Article 108159"},"PeriodicalIF":4.3,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Response to “National bowel cancer screening programs: The Emperor's new clothes!” 回应 "国家肠癌筛查计划：皇帝的新衣！"

IF 4.3 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Preventive medicine

Pub Date : 2024-10-28 DOI: 10.1016/j.ypmed.2024.108156

Joachim Worthington

引用次数: 0